The Chronic Use of Magnesium Decreases VEGF Levels in the Uterine Tissue in Rats
- 45 Downloads
Vascular endothelial growth factor (VEGF) is the most important regulator of angiogenesis which serves to provide sufficient blood supply, and can trigger both physiological and pathological angiogenesis. Recent studies have shown that VEGF increases in gynecological diseases (such as endometriosis, ovarian, and endometrial cancers) and is a prognostic factor in these pathologies. Therefore, VEGF should be maintained at appropriate levels. Magnesium is used in many gynecological practices (such as eclampsia, preeclampsia, dysmenorrhea, and climacteric symptoms) and the mechanisms of action are still under investigation. Redox status, which can be regulated by magnesium, was shown to affect VEGF expression. The aim of this study was to evaluate the effects of chronic magnesium use on VEGF and oxidative status in the uterus. Magnesium sulfate was administered to rats at doses of 30 mg/kg (intramuscular) for 2 weeks. VEGF, Superoxide dismutase (SOD), Glutathione peroxidase (GPx), and Malondialdehyde (MDA) levels were measured using ELISA; vascular and cellular alterations were determined by histology in the uterine tissue at the metoestrus phase. In the uterine tissue of Mg-treated subjects, magnesium levels increased while VEGF, SOD, GPx, and MDA levels decreased without histological changes. There was a negative correlation between uterine tissue magnesium levels and VEGF, SOD, GPx, and MDA levels. Consequently, the results of this study demonstrated that regular magnesium use decreased VEGF levels in uterus. Decreased VEGF levels were associated with decreased uterine oxidative stress. Chronic magnesium usage may protect the uterine tissue from certain diseases in which angiogenesis is critical.
KeywordsMagnesium VEGF Uterus SOD GPx MDA Oxidative status
Compliance with Ethical Standards
The experiments were carried out according to the guiding principles in the use of experimental animals and approved by the Animal Care and Use Committee of the Dokuz Eylül University, School of Medicine.
Conflict of Interest
The authors declare that they have no conflict of interest.
- 9.Belfort-Mattos PN, Focchi GRA, Ribalta JCL, Megale De Lima T, Nogueira Carvalho CR, Kesselring Tso F, De Góis Speck NM (2016) Immunohistochemical expression of VEGF and podoplanin in uterine cervical squamous intraepithelial lesions. Dis Markers 2016:8293196–8293196. https://doi.org/10.1155/2016/8293196 CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Ozawa CR, Banfi A, Glazer NL, Thurston G, Springer ML, Kraft PE, McDonald DM, Blau HM (2004) Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 113(4):516–527. https://doi.org/10.1172/jci18420 CrossRefPubMedPubMedCentralGoogle Scholar
- 18.Weintraub AY, Amash A, Eshkoli T, Piltcher Haber E, Bronfenmacher B, Sheiner E, Holcberg G, Huleihel M (2013) The effects of magnesium sulfate on placental vascular endothelial growth factor expression in preeclampsia. Hypertension in pregnancy 32(2):178–188. https://doi.org/10.3109/10641955.2013.784787 CrossRefPubMedGoogle Scholar
- 22.Scudamore CL (2014) A practical guide to the histology of the mouse. Available via http://worldcat.org. http://public.eblib.com/choice/publicfullrecord.aspx?p=1584994
- 24.Sahoo SS, Lombard JM, Ius Y, O’Sullivan R, Wood LG, Nahar P, Jaaback K, Tanwar PS (2018) Adipose-derived VEGF-mTOR signaling promotes endometrial hyperplasia and cancer: implications for obese women. Mol Cancer Res 16(2):309–321. https://doi.org/10.1158/1541-7786.mcr-17-0466 CrossRefPubMedGoogle Scholar
- 35.Kamath S, Varashree BS, John P, Mohapatra N, P. Shenoy R, Shetty R (2016) Correlation of serum magnesium and malondialdehyde levels in patients with myocardial infarction. Research Journal of Pharmaceutical, Biological and Chemical Sciences 7(5):791–795Google Scholar
- 37.Chiarello DI, Marin R, Proverbio F, Benzo Z, Piñero S, Botana D, Abad C (2014) Effect of hypoxia on the calcium and magnesium content, lipid peroxidation level, and Ca2+-ATPase activity of syncytiotrophoblast plasma membranes from placental explants. Biomed Res Int 2014:9. https://doi.org/10.1155/2014/597357 CrossRefGoogle Scholar
- 40.Reynolds A, Slattery S, Byrne S, Neary E, Mullers S, Kent E, Malone FD, El-Khuffash A, McGarvey C, Hayes BC (2017) Timing of administration of antenatal magnesium sulfate and umbilical cord blood magnesium levels in preterm babies. J Matern Fetal Neonatal Med. https://doi.org/10.1080/14767058.2017.1398724 1-6CrossRefGoogle Scholar
- 41.Das M, Chaudhuri PR, Mondal BC, Mitra S, Bandyopadhyay D, Pramanik S (2015) Assessment of serum magnesium levels and its outcome in neonates of eclamptic mothers treated with low-dose magnesium sulfate regimen. Indian J Pharm 47(5):502–508. https://doi.org/10.4103/0253-7613.165183 CrossRefGoogle Scholar